Related Experiment Video
Updated: Mar 24, 2026

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
Insomnia: the Sleeping Giant of Pediatric Public Health
Emily Badin1, Cynthia Haddad1, Jess Parker Shatkin2
1The Child Study Center at NYU Langone Medical Center, One Park Ave, 7th Floor, New York, NY, 10016, USA.
Insights
Pediatric insomnia significantly impacts youth and families, often going untreated. Behavioral therapies are recommended first-line treatments, with melatonin as a second-line option.
Area of Science:
- Pediatric Sleep Medicine
- Child and Adolescent Psychiatry
- Developmental Psychology
Background:
- Pediatric insomnia is widespread, affecting children's academic, emotional, and social development.
- It frequently goes undiagnosed and untreated, or is managed with non-FDA-approved medications.
- Untreated insomnia poses significant risks to healthy development in youth.
Purpose of the Study:
- To review sleep physiology in children and adolescents.
- To outline current and recommended assessment and treatment strategies for pediatric insomnia.
- To provide evidence-based recommendations for managing pediatric sleep disturbances.
Main Methods:
- A comprehensive literature review was conducted.
- Existing research on pediatric sleep physiology, assessment, and treatment was analyzed.
- Evidence for various treatment modalities was evaluated.
Main Results:
- Medications are often used but lack sufficient evidence for efficacy and safety in pediatric insomnia.
- Behavioral interventions, including cognitive behavior therapy for insomnia (CBT-I) and sleep hygiene, are effective first-line treatments.
- Melatonin may be considered as a second-line treatment option.
Conclusions:
- Comprehensive assessment and evidence-based treatment are crucial for pediatric insomnia.
- Behavioral therapies should be prioritized over pharmacotherapy for initial treatment.
- Addressing pediatric insomnia is vital for the well-being of children, adolescents, and their families.
Abstract:
Insomnia among children and adolescents is ubiquitous and takes a great toll on youth and their families, impacting academic achievement, mood, social functioning, and a variety of developmental outcomes. Unfortunately, however, pediatric insomnia most often remains unidentified and untreated. When treatment is provided, it is most often in the form of medications, which are not FDA approved for that indication in children and adolescents. A comprehensive literature review was employed to establish the recommendations in this report. This article provides a review of sleep physiology and both current and recommended approaches to assessing and treating pediatric insomnia. Comprehensive assessment, accurate diagnosis, and evidence-based treatment of insomnia is imperative to the healthy development of children and adolescents. While clinicians often prescribe a variety of medications to treat pediatric insomnia, there is insufficient data to demonstrate efficacy and endorse their routine use. At this time, behavioral techniques, such as cognitive behavior therapy for insomnia and sleep hygiene education, should remain the first line of treatment. As a second-line consideration, melatonin, a dietary supplement, may be effective. Pediatric insomnia has an enormous impact on children, adolescents, and their families that requires adequate attention from clinicians and parents alike.
Related Concept Videos
Insomnia
Multiple factors contribute...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Management of Insomnia
Pharmacokinetics in Pediatric Patients: Drug Excretion
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Nightmares and Night Terrors
Nightmares...

